Massachusetts Wealth Management increased its position in shares of Morgan Stanley (NYSE:MS – Free Report) by 9.4% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 1,752 shares of the financial services provider’s stock after acquiring an additional 150 shares during the period. Massachusetts Wealth Management’s holdings in Morgan Stanley were worth $204,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Brighton Jones LLC grew its position in shares of Morgan Stanley by 10.2% in the 4th quarter. Brighton Jones LLC now owns 12,782 shares of the financial services provider’s stock valued at $1,607,000 after buying an additional 1,185 shares during the last quarter. Allspring Global Investments Holdings LLC grew its position in shares of Morgan Stanley by 6.6% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 120,200 shares of the financial services provider’s stock valued at $14,999,000 after buying an additional 7,407 shares during the last quarter. Van ECK Associates Corp grew its position in shares of Morgan Stanley by 1,343.0% in the 4th quarter. Van ECK Associates Corp now owns 29,813 shares of the financial services provider’s stock valued at $3,748,000 after buying an additional 27,747 shares during the last quarter. Naples Global Advisors LLC bought a new stake in shares of Morgan Stanley in the 4th quarter valued at about $218,000. Finally, Bogart Wealth LLC grew its position in shares of Morgan Stanley by 14.2% in the 4th quarter. Bogart Wealth LLC now owns 1,108 shares of the financial services provider’s stock valued at $139,000 after buying an additional 138 shares during the last quarter. Institutional investors own 84.19% of the company’s stock.
Morgan Stanley Stock Down 1.9%
MS stock opened at $129.44 on Friday. The stock’s 50 day simple moving average is $121.25 and its 200 day simple moving average is $125.18. Morgan Stanley has a fifty-two week low of $90.94 and a fifty-two week high of $142.03. The company has a debt-to-equity ratio of 3.14, a quick ratio of 0.80 and a current ratio of 0.80. The company has a market cap of $207.67 billion, a P/E ratio of 16.30, a price-to-earnings-growth ratio of 1.18 and a beta of 1.29.
Morgan Stanley Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Thursday, May 15th. Investors of record on Wednesday, April 30th were paid a dividend of $0.925 per share. This represents a $3.70 dividend on an annualized basis and a yield of 2.86%. The ex-dividend date was Wednesday, April 30th. Morgan Stanley’s dividend payout ratio (DPR) is currently 43.43%.
Wall Street Analysts Forecast Growth
A number of equities research analysts have commented on MS shares. Wells Fargo & Company reduced their price target on Morgan Stanley from $130.00 to $120.00 and set an “equal weight” rating on the stock in a research report on Monday, April 14th. Erste Group Bank upgraded Morgan Stanley from a “hold” rating to a “strong-buy” rating in a research report on Saturday, May 24th. JMP Securities reiterated a “market perform” rating on shares of Morgan Stanley in a research report on Monday, April 14th. Bank of America reduced their price target on Morgan Stanley from $150.00 to $144.00 and set a “buy” rating on the stock in a research report on Wednesday, April 2nd. Finally, Citigroup dropped their price objective on Morgan Stanley from $135.00 to $125.00 and set a “neutral” rating on the stock in a research note on Monday, March 24th. Eleven equities research analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $133.23.
Get Our Latest Stock Report on Morgan Stanley
Insider Buying and Selling
In other Morgan Stanley news, Director Robert H. Herz sold 800 shares of the business’s stock in a transaction that occurred on Friday, May 2nd. The stock was sold at an average price of $119.32, for a total transaction of $95,456.00. Following the completion of the sale, the director now directly owns 96,760 shares of the company’s stock, valued at approximately $11,545,403.20. The trade was a 0.82% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Andrew M. Saperstein sold 40,000 shares of the business’s stock in a transaction that occurred on Friday, May 2nd. The stock was sold at an average price of $120.00, for a total value of $4,800,000.00. Following the sale, the insider now directly owns 335,765 shares of the company’s stock, valued at $40,291,800. This represents a 10.64% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 50,868 shares of company stock valued at $6,019,548. 0.19% of the stock is owned by company insiders.
About Morgan Stanley
Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. It operates through Institutional Securities, Wealth Management, and Investment Management segments.
Featured Stories
- Five stocks we like better than Morgan Stanley
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Synopsys Stock Falls on China Ban, But Long-Term Outlook Holds
- When to Sell a Stock for Profit or Loss
- Alphabet Enters a Bull Market: Is It Time to Buy?
- How Technical Indicators Can Help You Find Oversold Stocks
- Ouster Soars 27% as DoD Grants First 3D LiDAR Approval for Drones
Want to see what other hedge funds are holding MS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Morgan Stanley (NYSE:MS – Free Report).
Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.